{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:09:20Z","timestamp":1773767360265,"version":"3.50.1"},"reference-count":30,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/etm.2014.1682","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T08:11:31Z","timestamp":1397463091000},"page":"95-99","source":"Crossref","is-referenced-by-count":21,"title":["NF-\u03baB inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells"],"prefix":"10.3892","volume":"8","author":[{"given":"FEI","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUYUAN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAIPING","family":"DU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAO","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHIYONG","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINGWANG","family":"YAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,4,14]]},"reference":[{"key":"key20180108131026_b1-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"key20180108131026_b2-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"key20180108131026_b3-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180108131026_b4-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ncpgasthep0813","article-title":"Reversibility of hepatic fibrosis and cirrhosis - is it all hype?","volume":"4","author":"Friedman","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key20180108131026_b5-etm-08-01-0095","first-page":"100","article-title":"Cirrhosis - can we reverse hepatic fibrosis?","volume":"587","author":"Tangkijvanich","year":"2002","journal-title":"Eur J Surg Suppl"},{"key":"key20180108131026_b6-etm-08-01-0095","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"Povero","year":"2010","journal-title":"Histol Histopathol"},{"key":"key20180108131026_b7-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180108131026_b8-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"key20180108131026_b9-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/A812","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front Biosci"},{"key":"key20180108131026_b10-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","article-title":"Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases","volume":"28","author":"Gressner","year":"2008","journal-title":"Liver Int"},{"key":"key20180108131026_b11-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/CS20090549","article-title":"Role of nuclear factor kappaB in liver health and disease","volume":"118","author":"Robinson","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"key20180108131026_b12-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/hep.24475","article-title":"Cell line misidentification: the case of the Chang liver cell line","volume":"54","author":"Gao","year":"2011","journal-title":"Hepatology"},{"key":"key20180108131026_b13-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2012.148","article-title":"Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl(4)-induced hepatic fibrosis in mice","volume":"20","author":"Hao","year":"2012","journal-title":"Mol Ther"},{"key":"key20180108131026_b14-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/eji.201040533","article-title":"Cystatin cures visceral leishmaniasis by NF-\u03baB-mediated proinflammatory response through co-ordination of TLR\/MyD88 signaling with p105-TpI2-ERK pathway","volume":"41","author":"Kar","year":"2011","journal-title":"Eur J Immunol"},{"key":"key20180108131026_b15-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.intimp.2013.05.027","article-title":"Bay11\u20137082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-\u03baB activation","volume":"17","author":"Zhao","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"key20180108131026_b16-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver - linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20180108131026_b17-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0016-5085(03)01194-6","article-title":"The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C","volume":"125","author":"Bonacchi","year":"2003","journal-title":"Gastroenterology"},{"key":"key20180108131026_b18-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"key20180108131026_b19-etm-08-01-0095","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J Clin Invest"},{"key":"key20180108131026_b20-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180108131026_b21-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180108131026_b22-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"G631","DOI":"10.1152\/ajpgi.00185.2007","article-title":"Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis","volume":"293","author":"Son","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20180108131026_b23-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"key20180108131026_b24-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/hep.510270514","article-title":"Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor","volume":"27","author":"Hellerbrand","year":"1998","journal-title":"Hepatology"},{"key":"key20180108131026_b25-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1053\/j.gastro.2009.02.081","article-title":"Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis","volume":"136","author":"Oakley","year":"2009","journal-title":"Gastroenterology"},{"key":"key20180108131026_b26-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.4049\/jimmunol.166.11.6812","article-title":"CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells","volume":"166","author":"Schwabe","year":"2001","journal-title":"J Immunol"},{"key":"key20180108131026_b27-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.510300327","article-title":"Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins","volume":"30","author":"Elsharkawy","year":"1999","journal-title":"Hepatology"},{"key":"key20180108131026_b28-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2009.09.015","article-title":"Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition","volume":"138","author":"Kluwe","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180108131026_b29-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1021\/jm300847w","article-title":"PI3K\u03b4 and PI3K\u03b3 as targets for autoimmune and inflammatory diseases","volume":"55","author":"Cushing","year":"2012","journal-title":"J Med Chem"},{"key":"key20180108131026_b30-etm-08-01-0095","doi-asserted-by":"crossref","first-page":"G1401","DOI":"10.1152\/ajpgi.00062.2008","article-title":"PI3K\/Akt activation is critical for early hepatic regeneration after partial hepatectomy","volume":"294","author":"Jackson","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.1682\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T18:02:44Z","timestamp":1515434564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.1682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,4,14]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/etm.2014.1682"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.1682","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,14]]}}}